Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ishizaki, K.
Right arrow Articles by Fujita, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishizaki, K.
Right arrow Articles by Fujita, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, Vol 75, Issue 5 636-638, Copyright © 1995 by The Board of Management and Trustees of the British Journal of Anaesthesia


SHORT COMMUNICATIONS

Intrathecal administration of N-methyl-D-aspartate receptor antagonist reduces the minimum alveolar anaesthetic concentration of isoflurane in rats

K. Ishizaki, D. M. Yoon, N. Yoshida, M. Yamazaki, K. Arai and T. Fujita
Department of Anesthesiology and Reanimatology, School of Medicine, Gunma University, 3-39-22 Shouwamathi, Maebashi 371, Japan

We have studied the effect of intrathecal administration of N-methyl-D- aspartate (NMDA) receptor antagonists on the minimum alveolar anaesthetic concentration (MAC) of isoflurane in rats. In Wistar rats fitted with indwelling intrathecal catheters, we determined the MAC of isoflurane after administration of a competitive NMDA receptor antagonist, APV (0.01, 0.1, 1.0, 10, 30 micrograms), a non-competitive NMDA receptor antagonist, MK801 (0.1, 1.0, 10, 30 micrograms). NMDA (0.01, 0.1, 1.0, 10, 30 micrograms) and saline. APV at all doses except 0.01 micrograms decreased MAC by 17.1-32% (P < 0.001 and P < 0.0001). Although MK801 at 10 and 30 micrograms reduced MAC by 24.3-31.7% (P < 0.001 and P < 0.0001), lower doses did not affect MAC. Intrathecal administration of NMDA reversed these decreases in MAC, but not to control values with APV 10 and 30 micrograms and MK801 30 micrograms. We suspect that NMDA and NMDA receptor antagonists play important roles in the spinal cord in determining the MAC of isoflurane.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
E. I. Eger II, D. E. Raines, S. L. Shafer, H. C. Hemmings Jr, and J. M. Sonner
Is a New Paradigm Needed to Explain How Inhaled Anesthetics Produce Immobility?
Anesth. Analg., September 1, 2008; 107(3): 832 - 848.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. I. Eger II, M. Liao, M. J. Laster, A. Won, J. Popovich, D. E. Raines, K. Solt, R. C. Dutton, F. V. Cobos II, and J. M. Sonner
Contrasting Roles of the N-Methyl-d-Aspartate Receptor in the Production of Immobilization by Conventional and Aromatic Anesthetics.
Anesth. Analg., May 1, 2006; 102(5): 1397 - 1406.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M.-A. Docquier, P. Lavand'homme, V. Boulanger, V. Collet, and M. De Kock
Questioning the cardiocirculatory excitatory effects of opioids under volatile anaesthesia
Br. J. Anaesth., September 1, 2004; 93(3): 408 - 413.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. M. Sonner, J. F. Antognini, R. C. Dutton, P. Flood, A. T. Gray, R. A. Harris, G. E. Homanics, J. Kendig, B. Orser, D. E. Raines, et al.
Inhaled Anesthetics and Immobility: Mechanisms, Mysteries, and Minimum Alveolar Anesthetic Concentration
Anesth. Analg., September 1, 2003; 97(3): 718 - 740.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C. Stabernack, J. M. Sonner, M. Laster, Y. Zhang, Y. Xing, M. Sharma, and E. I. Eger II
Spinal N-Methyl-D-Aspartate Receptors May Contribute to the Immobilizing Action of Isoflurane
Anesth. Analg., January 1, 2003; 96(1): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
N. Nishizawa, T. Shirasaki, S. Nakao, H. Matsuda, and K. Shingu
The Inhibition of the N-Methyl-D-Aspartate Receptor Channel by Local Anesthetics in Mouse CA1 Pyramidal Neurons
Anesth. Analg., February 1, 2002; 94(2): 325 - 330.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. Zhang, S. Wu, E. I Eger II, and J. M. Sonner
Neither GABAA nor Strychnine-Sensitive Glycine Receptors Are the Sole Mediators of MAC for Isoflurane
Anesth. Analg., January 1, 2001; 92(1): 123 - 127.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.